Related Experiment Video
Updated: May 9, 2026
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Update in pediatric optic neuritis
Janine E Collinge1, Derek T Sprunger
1Department of Pediatric Ophthalmology and Adult Strabismus, Indiana University Health, Indianapolis, Indiana, USA. janine.collinge@gmail.com
Insights
Pediatric optic neuritis differs from adult forms, with new research clarifying its features and links to demyelinating diseases. Corticosteroids are standard treatment, but further trials are needed for optimal management.
Area of Science:
- Ophthalmology
- Neurology
- Pediatrics
Background:
- Pediatric optic neuritis presents distinct features compared to adult cases.
- Early recognition is crucial for patient evaluation and prognosis.
- Understanding its association with progressive demyelinating disorders is vital.
Purpose of the Study:
- To review current understanding of pediatric optic neuritis.
- To highlight recent advancements in diagnosis and management.
- To identify knowledge gaps and future research directions.
Main Methods:
- Review of recent studies on pediatric optic neuritis.
- Analysis of demographic and presenting features.
- Evaluation of emerging biomarkers and optical coherence tomography (OCT) utility.
Main Results:
- Expanded knowledge of pediatric optic neuritis demographics and presentation.
- Biomarkers and OCT show potential prognostic value.
- Better understanding of risk factors for progression to systemic demyelinating processes like multiple sclerosis.
- Corticosteroids remain the primary treatment; immunosuppressive therapies show success in refractory cases.
Conclusions:
- Comprehensive understanding and optimal management of pediatric optic neuritis are still developing.
- A randomized clinical trial is needed to advance knowledge and improve patient outcomes.
Purpose Of Review:
Pediatric optic neuritis is an uncommon disorder with significant distinctions from its adult counterpart. Recognizing the features of this disorder and the potential association with progressive demyelinating processes is important for patients' evaluation and prognosis.
Recent Findings:
In the last few years, studies have expanded our understanding of demographic and presenting features for optic neuritis in the pediatric population. Emerging research on biomarkers and optical coherence tomography utility offers potential prognostic value in patient management. In addition, pooled research data have allowed for better understanding of the risks factors for progression from isolated optic neuritis to systemic demyelinating processes, such as multiple sclerosis. Although definitive evidence is lacking, corticosteroids remain the cornerstone of treatment. Various other immunosuppressive therapy studies have also reported success, particularly in refractory cases.
Summary:
A comprehensive understanding of pediatric optic neuritis and its management remains elusive. A randomized clinical trial would potentially increase our knowledge and benefit the afflicted patients.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
01:25Glaucoma: Overview